PUZO MICHAEL J - NOVOZYMES A S DKK 2.0 ownership

NOVOZYMES A S DKK 2.0's ticker is and the CUSIP is B798FW902. A total of 6 filers reported holding NOVOZYMES A S DKK 2.0 in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PUZO MICHAEL J ownership history of NOVOZYMES A S DKK 2.0
ValueSharesWeighting
Q3 2023$385,859
-36.7%
9,585
-26.9%
0.13%
-32.1%
Q2 2023$609,360
-10.2%
13,120
-1.5%
0.19%
-14.6%
Q1 2023$678,197
-21.3%
13,320
-22.0%
0.23%
-27.3%
Q4 2022$861,995
-9.7%
17,070
-9.9%
0.31%
-14.3%
Q3 2022$955,000
-34.3%
18,945
-22.0%
0.36%
-29.7%
Q2 2022$1,454,000
-39.2%
24,275
-30.3%
0.52%
-28.3%
Q1 2022$2,392,000
-36.4%
34,825
-24.1%
0.72%
-32.2%
Q4 2021$3,761,000
+1.1%
45,900
-15.7%
1.06%
-9.9%
Q3 2021$3,720,000
-21.4%
54,440
-13.5%
1.18%
-19.9%
Q2 2021$4,735,000
-11.4%
62,960
-24.7%
1.47%
-13.5%
Q1 2021$5,342,000
+6.5%
83,635
-4.6%
1.70%
+3.8%
Q4 2020$5,016,000
-14.3%
87,630
-6.0%
1.64%
-21.4%
Q3 2020$5,856,000
+8.1%
93,200
-0.8%
2.08%
+2.9%
Q2 2020$5,416,000
+23.0%
93,960
-2.8%
2.03%
+4.5%
Q1 2020$4,403,000
-6.7%
96,625
-0.1%
1.94%
+14.7%
Q4 2019$4,720,000
+14.4%
96,705
-1.8%
1.69%
+8.7%
Q3 2019$4,127,000
-10.0%
98,445
-0.2%
1.55%
-8.7%
Q2 2019$4,586,000
+1.3%
98,6600.0%1.70%
-3.5%
Q1 2019$4,526,000
+2.8%
98,660
-0.2%
1.76%
-9.8%
Q4 2018$4,401,000
-20.7%
98,830
-2.6%
1.96%
-6.7%
Q3 2018$5,552,000
+5.8%
101,470
-2.0%
2.10%
-5.7%
Q2 2018$5,247,000
-4.0%
103,570
-2.3%
2.22%
-4.6%
Q1 2018$5,466,000
-10.2%
106,055
-0.7%
2.33%
-7.2%
Q4 2017$6,087,000
+38.2%
106,845
+24.3%
2.51%
+9.5%
Q3 2017$4,403,000
+16.3%
85,985
-0.6%
2.29%
+12.1%
Q2 2017$3,787,000
+13.7%
86,485
+2.9%
2.04%
+10.4%
Q1 2017$3,332,000
+16.7%
84,060
+1.6%
1.85%
+12.0%
Q4 2016$2,855,000
-18.4%
82,770
+4.1%
1.65%
-18.1%
Q3 2016$3,497,000
-5.0%
79,520
+4.0%
2.02%
-16.9%
Q2 2016$3,680,000
+10.0%
76,495
+2.8%
2.43%
+9.4%
Q1 2016$3,346,000
-5.5%
74,445
+1.2%
2.22%
-10.2%
Q4 2015$3,541,000
+11.9%
73,545
+1.2%
2.47%
+10.0%
Q3 2015$3,165,000
-8.6%
72,645
-0.3%
2.25%
+0.8%
Q2 2015$3,463,000
+4.3%
72,845
+0.4%
2.23%
+5.2%
Q1 2015$3,321,000
+9.0%
72,555
+0.5%
2.12%
+6.0%
Q4 2014$3,047,000
-1.6%
72,200
+1.1%
2.00%
-5.9%
Q3 2014$3,098,000
-16.2%
71,405
-3.1%
2.13%
-17.1%
Q2 2014$3,696,000
+15.2%
73,680
+1.1%
2.56%
+11.1%
Q1 2014$3,207,000
+3.6%
72,910
-0.6%
2.31%
+2.3%
Q4 2013$3,095,000
+15.9%
73,330
+5.1%
2.26%
+1.1%
Q3 2013$2,670,000
+20.4%
69,780
+0.7%
2.23%
+14.7%
Q2 2013$2,217,000
-6.7%
69,280
-1.1%
1.95%
-6.1%
Q1 2013$2,377,000
+15.3%
70,080
-4.4%
2.07%
+5.3%
Q4 2012$2,062,00073,2881.97%
Other shareholders
NOVOZYMES A S DKK 2.0 shareholders Q3 2023
NameSharesValueWeighting ↓
SOMERVILLE KURT F 201,293$11,524,0001.88%
Broderick Brian C 103,399$5,920,0001.76%
PUZO MICHAEL J 87,630$5,016,0001.64%
Page Arthur B 37,110$2,124,0001.60%
Kidder Stephen W 82,525$4,725,0001.57%
Dempze Nancy E 26,868$1,538,0001.41%
Hemenway Trust Co LLC 206,884$11,844,0001.36%
Notis-McConarty Edward 32,876$1,882,0000.77%
View complete list of NOVOZYMES A S DKK 2.0 shareholders